Inhibition of Navβ4 peptide-mediated resurgent sodium currents in Nav1.7 channels by carbamazepine, riluzole, and anandamide

Molecular Pharmacology

Volumn 80, Issue 4, 2011, Pages 724-734

  Theile, Jonathan W ^a   Cummins, Theodore R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CARBAMAZEPINE; RILUZOLE; SODIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL NAV1.7;

ARTICLE; CELL STRAIN HEK293; DRUG MECHANISM; HUMAN; HUMAN CELL; NERVE CELL EXCITABILITY; PRIORITY JOURNAL; SODIUM CURRENT; WILD TYPE;

ACTION POTENTIALS; ARACHIDONIC ACIDS; CARBAMAZEPINE; ERYTHROMELALGIA; HEK293 CELLS; HUMANS; MUTATION; POLYUNSATURATED ALKAMIDES; RILUZOLE; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS;

EID: 80053185917     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.072751     Document Type: Article

References (39)

1. Bant JS and Raman IM (2010) Control of transient, resurgent, and persistent current by open-channel block by Na channel beta4 in cultured cerebellar granule neurons. Proc Natl Acad Sci USA 107:12357-12362.
2. Bean BP (2007) The action potential in mammalian central neurons. Nat Rev Neurosci 8:451-465.
3. Bendahhou S, Cummins TR, and Agnew WS (1997) Mechanism of modulation of the voltage-gated skeletal and cardiac muscle sodium channels by fatty acids. Am J Physiol 272:C592-C600.
4. Bensimon G, Lacomblez L, and Meininger V (1994) A controlled trial of riluzole inamyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330:585-591. (Pubitemid 24065791)
5. Breton H, Cociglio M, Bressolle F, Peyriere H, Blayac JP, and Hillaire-Buys D (2005) Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 828:80-90. (Pubitemid 41735303)
6. Calignano A, La Rana G, Giuffrida A, and Piomelli D (1998) Control of pain initiation by endogenous cannabinoids. Nature 394:277-281. (Pubitemid 28335039)
7. Catterall WA, Goldin AL, and Waxman SG (2005) International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 57:397-409. (Pubitemid 43036431)
8. Cummins TR, Dib-Hajj SD, Herzog RI, and Waxman SG (2005) Nav1.6 channels generate resurgent sodium currents in spinal sensory neurons. FEBS Lett 579: 2166-2170. (Pubitemid 40469688)
9. Cummins TR, Dib-Hajj SD, and Waxman SG (2004) Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J Neurosci 24:8232-8236. (Pubitemid 39280802)
10. Dib-Hajj SD, Cummins TR, Black JA, and Waxman SG (2007) From genes to pain: Na v 1.7 and human pain disorders. Trends Neurosci 30:555-563. (Pubitemid 350051424)
11. Dib-Hajj SD, Estacion M, Jarecki BW, Tyrrell L, Fischer TZ, Lawden M, Cummins TR, and Waxman SG (2008) Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable. Mol Pain 4:37.
12. Dib-Hajj SD, Rush AM, Cummins TR, Hisama FM, Novella S, Tyrrell L, Marshall L, and Waxman SG (2005) Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 128:1847-1854. (Pubitemid 41373656)
13. England S and De Groot MJ (2009) Subtype-selective targeting of voltage-gated sodium channels. Br J Pharmacol 158:1413-1425.
14. Estacion M, Waxman SG, and Dib-Hajj SD (2010) Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability. Mol Pain 6:35.
15. Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahamsen B, Ostman J, Klugbauer N, Wood JN, Gardiner RM, et al. (2006) SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52:767-774. (Pubitemid 44828442)
16. Fertleman CR, Ferrie CD, Aicardi J, Bednarek NA, Eeg-Olofsson O, Elmslie FV, Griesemer DA, Goutières F, Kirkpatrick M, Malmros IN, et al. (2007) Paroxysmal extreme pain disorder (previously familial rectal pain syndrome). Neurology 69: 586-595. (Pubitemid 47357266)
17. Fischer TZ, Gilmore ES, Estacion M, Eastman E, Taylor S, Melanson M, Dib-Hajj SD, and Waxman SG (2009) A novel Nav1.7 mutation producing carbamazepineresponsive erythromelalgia. Ann Neurol 65:733-741.
18. Grieco TM, Malhotra JD, Chen C, Isom LL, and Raman IM (2005) Open-channel block by the cytoplasmic tail of sodium channel beta4 as a mechanism for resurgent sodium current. Neuron 45:233-244. (Pubitemid 40128117)
19. Hargus NJ, Merrick EC, Nigam A, Kalmar CL, Baheti AR, Bertram EH 3rd, and Patel MK (2011) Temporal lobe epilepsy induces intrinsic alterations in Na channel gating in layer II medial entorhinal cortex neurons. Neurobiol Dis 41:361-376.
20. Jarecki BW, Piekarz AD, Jackson JO 2nd, and Cummins TR (2010) Human voltagegated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents. J Clin Invest 120:369-378.
21. Jarecki BW, Sheets PL, Jackson JO 2nd, and Cummins TR (2008) Paroxysmal extreme pain disorder mutations within the D3/S4-S5 linker of Nav1.7 cause moderate destabilization of fast inactivation. J Physiol 586:4137-4153.
22. Khaliq ZM, Gouwens NW, and Raman IM (2003) The contribution of resurgent sodium current to high-frequency firing in Purkinje neurons: an experimental and modeling study. J Neurosci 23:4899-4912. (Pubitemid 36793216)
23. Kim HI, Kim TH, Shin YK, Lee CS, Park M, and Song JH (2005) Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons. Brain Res 1062:39-47. (Pubitemid 41612127)
24. Klugbauer N, Lacinova L, Flockerzi V, and Hofmann F (1995) Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J 14:1084-1090.
25. Lai J, Gold MS, Kim CS, Bian D, Ossipov MH, Hunter JC, and Porreca F (2002) Inhibition of neuropathic pain by decreased expression of the tetrodotoxinresistant sodium channel, NaV1.8. Pain 95:143-152. (Pubitemid 34076786)
26. Nicholson RA, Liao C, Zheng J, David LS, Coyne L, Errington AC, Singh G, and Lees G (2003) Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res 978:194-204. (Pubitemid 36776639)
27. Priest BT, Murphy BA, Lindia JA, Diaz C, Abbadie C, Ritter AM, Liberator P, Iyer LM, Kash SF, Kohler MG, et al. (2005) Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci USA 102:9382-9387. (Pubitemid 40923572)
28. + channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs. Mol Pharmacol 40:756-765.
29. Raman IM and Bean BP (1997) Resurgent sodium current and action potential formation in dissociated cerebellar Purkinje neurons. J Neurosci 17:4517-4526. (Pubitemid 27246909)
30. Raman IM and Bean BP (2001) Inactivation and recovery of sodium currents in cerebellar Purkinje neurons: evidence for two mechanisms. Biophys J 80:729-737. (Pubitemid 32128326)
31. Rogawski MA and Löscher W (2004) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10:685-692. (Pubitemid 38937632)
32. Romettino S, Lazdunski M, and Gottesmann C (1991) Anticonvulsant and sleepwaking influences of riluzole in a rat model of absence epilepsy. Eur J Pharmacol 199:371-373.
33. Rush AM, Dib-Hajj SD, Liu S, Cummins TR, Black JA, and Waxman SG (2006) A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci USA 103:8245-8250. (Pubitemid 43801083)
34. Song JH, Huang CS, Nagata K, Yeh JZ, and Narahashi T (1997) Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels. J Pharmacol Exp Ther 282:707-714. (Pubitemid 27340171)
35. Theile JW, Jarecki BW, Piekarz AD, and Cummins TR (2011) Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Nav{beta}4 peptide-mediated resurgent sodium currents. J Physiol 589: 597-608.
36. Urbani A and Belluzzi O (2000) Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci 12:3567-3574.
37. Waxman SG and Dib-Hajj S (2005) Erythermalgia: molecular basis for an inherited pain syndrome. Trends Mol Med 11:555-562. (Pubitemid 41713997)
38. Weiss S, Benoist D, White E, Teng W, and Saint DA (2010) Riluzole protects against cardiac ischaemia and reperfusion damage via block of the persistent sodium current. Br J Pharmacol 160:1072-1082.
39. Zgrajka W, Nieoczym D, Czuczwar M, Kiś J, Brzana W, Wlaź P, and Turski WA (2010) Evidences for pharmacokinetic interaction of riluzole and topiramate with pilocarpine in pilocarpine-induced seizures in rats. Epilepsy Res 88:269-274.